461 related articles for article (PubMed ID: 28135896)
1. Enhanced dissolution of sildenafil citrate as dry foam tablets.
Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
[TBL] [Abstract][Full Text] [Related]
2. Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation.
Hosny KM; Mosli HA; Hassan AH
Drug Des Devel Ther; 2015; 9():465-72. PubMed ID: 25624751
[TBL] [Abstract][Full Text] [Related]
3. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Meka VS; Yee P; Sheshala R
Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
[TBL] [Abstract][Full Text] [Related]
4. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets.
Braig V; Konnerth C; Peukert W; Lee G
Int J Pharm; 2019 Jan; 554():54-60. PubMed ID: 30278257
[TBL] [Abstract][Full Text] [Related]
6. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
[TBL] [Abstract][Full Text] [Related]
7. Improving the hardness of dry granulated tablets containing sodium lauryl sulfate.
Moore F; Okelo G; Colón I; Kushner J
Int J Pharm; 2010 Nov; 400(1-2):37-41. PubMed ID: 20801204
[TBL] [Abstract][Full Text] [Related]
8. Impact of fillers on dissolution kinetic of fenofibrate dry foams.
Lenz E; Sprunk A; Kleinebudde P; Page S
Pharm Dev Technol; 2015; 20(5):570-8. PubMed ID: 24901031
[TBL] [Abstract][Full Text] [Related]
9. Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation.
Khan FN; Dehghan MH
AAPS PharmSciTech; 2011 Dec; 12(4):1077-86. PubMed ID: 21879394
[TBL] [Abstract][Full Text] [Related]
10. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
11. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug.
Sprunk A; Page S; Kleinebudde P
Int J Pharm; 2013 Oct; 455(1-2):189-96. PubMed ID: 23891743
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
13. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
14. Functionality of disintegrants with different mechanisms after roll compaction.
Berkenkemper S; Keizer HL; Lindenberg M; Szepes A; Kleinebudde P
Int J Pharm; 2020 Jun; 584():119434. PubMed ID: 32439584
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
16. An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension.
Zayed R; Kamel AO; Shukr M; El-Shamy Ael-H
Acta Pharm; 2012 Nov; 62(3):411-32. PubMed ID: 23470352
[TBL] [Abstract][Full Text] [Related]
17. Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.
Abdelkader H; Abdalla OY; Salem H
AAPS PharmSciTech; 2007 Nov; 8(4):E100. PubMed ID: 18181521
[TBL] [Abstract][Full Text] [Related]
18. HIGH SHEAR GRANULATION PROCESS: ASSESSING IMPACT OF FORMULATION VARIABLES ON GRANULES AND TABLETS CHARACTERISTICS OF HIGH DRUG LOADING FORMULATION USING DESIGN OF EXPERIMENT METHODOLOGY.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Ali BE
Acta Pol Pharm; 2017 Mar; 74(2):551-564. PubMed ID: 29624260
[TBL] [Abstract][Full Text] [Related]
19. Effects of liquisolid formulations on dissolution of naproxen.
Tiong N; Elkordy AA
Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
[TBL] [Abstract][Full Text] [Related]
20. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
Bejugam NK; Mutyam SK; Shankar GN
Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]